Intellia Therapeutics, Inc.NTLA
Close of Friday, October 23, 2026 · Intellia Therapeutics, Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$11.21
vs its Pivot
-14.1%
OnlyAlpha Score
36
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -7.8% | +24.7% | -54.4% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.12%IWM · 0.06%
Big investors that own it (latest 13F)
| RA Capital Peter Kolchinsky | 0.7% of holdings |
| Baker Bros. Advisors Julian and Felix Baker | 0.1% of holdings |
Members of Congress who traded it
| Don Beyer D · VA | 4 buys · 6 sells · last sell 2022-02-28 |
| James M. Inhofe R · OK | 1 buys · 1 sells · last sell 2018-10-25 |
| Tom Carper D · DE | 1 buys · 0 sells · last buy 2020-11-20 |
Get NTLA in your free daily emailAfter every close: whether NTLA is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track NTLA free → Full Stock check
Track NTLA free → Full Stock check